Publications
Publications 1151 - 1175 de 33557
Titre | DOI |
---|---|
A phase II study of lenalidomide in platinum-sensitive recurrent ovarian carcinoma F. Selle; E. Sevin; I. Ray-Coquard; V. Mari; D. Berton-Rigaud; L. Favier; M. Fabbro; A. Lesoin; A. Lortholary; E. Pujade-Lauraine 2014 |
10.1093/annonc/mdu392 |
A phase II study of monalizumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN): Results of the I1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM) R. Galot; C. Le Tourneau; E. Saada-Bouzid; A. Daste; C. Even; P.R. Debruyne; S. Henry; S. Zanetta; A. Rutten; L.F. Licitra; J.L. Canon; M.C. Kaminsky-Forrett; P. Specenier; S. Rottey; L. Dirix; T. Raveloarivahy; F. Lefevre; M.B.M. Vanlancker; A.S. Govaerts; J.P. Machiels 2019 |
|
A phase II study of the oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma E. Van Den Neste; M. Andre; T. Gastinne; A. Stamatoullas; C. Haioun; A. Belhabri; O. Reman; O. Casasnovas; H. Ghesquieres; G. Verhoef; M.J. Claessen; H.A. Poirel; M.C. Copin; R. Dubois; P. Vandenberghe; I.A. Stoian; A.S. Cottereau; S. Bailly; L. Knoops; F. Morschhauser 2018 |
10.3324/haematol.2017.180554 |
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1) H. Bonnefoi; T. Grellety; O. Tredan; M. Saghatchian; F. Dalenc; A. Mailliez; T. L'Haridon; P. Cottu; S. Abadie-Lacourtoisie; B. You; M. Mousseau; J. Dauba; F. Del Piano; I. Desmoulins; F. Coussy; N. Madranges; J. Grenier; F.C. Bidard; C. Proudhon; G. MacGrogan; C. Orsini; M. Pulido; A. Goncalves 2016 |
10.1093/annonc/mdw067 |
A phase II trial of sorafenib (SO) in advanced chordoma patients (pt) E. Amela; E. Bompas; A. Le Cesne; E. Tresch; A. Italiano; S. Piperno-Neumann; O. Collard; D. Vansteene; J. Domont; E. Saada; N. Isambert; S. Salas; C. Chevreau; F. Bertucci; S.Clisant Delaine; J.Y. Blay; N. Penel 2015 |
|
A phase II, single-arm, multicentre study of coltuximab ravtansine (SAR3419) and rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma B. Coiffier; C. Thieblemont; S. de Guibert; J. Dupuis; V. Ribrag; R. Bouabdallah; F. Morschhauser; R. Navarro; S. Le Gouill; C. Haioun; R. Houot; O. Casasnovas; H. Holte; T. Lamy; F. Broussais; S. Payrard; L. Hatteville; H. Tilly 2016 |
10.1111/bjh.13992 |
A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: The TRUSTS trial B. Bui-Nguyen; J.E. Butrynski; N. Penel; J.Y. Blay; N. Isambert; M. Milhem; J.M. Kerst; A.K.L. Reyners; S. Litiere; S. Marreaud; F. Collin; W.T.A. van der Graaf; E.O.R.T.C. STBSG; SARC 2015 |
10.1016/j.ejca.2015.03.023 |
A phase III trial of empiric chemotherapy with cisplatin and gemcitabine or systemic treatment tailored by molecular gene expression analysis in patients with carcinomas of an unknown primary (CUP) site (GEFCAPI 04) K. Fizazi; A. Maillard; N. Penel; G. Baciarello; D. Allouache; G. Daugaard; A. van de Wouw; G. Soler; E. Vauleon; L. Chaigneau; R. Janssen; L. Gaspa; M. Barrera; C. Balana; D. Tosi; B. Chauffert; C.A. Schnabel; G. Martineau; S. Culine; I. Borget 2019 |
10.1093/annonc/mdz394 |
A Phase Transition for Large Values of Bifurcating Autoregressive Models V. Bansaye; V.Bitseki Penda 2021 |
10.1007/s10959-020-01033-w |
A phase-based framework for optical flow estimation on omnidirectional images B. Alibouch; A. Radgui; C. Demonceaux; M. Rziza; D. Aboutajdine 2016 |
10.1007/s11760-014-0739-z |
A phase-by-phase upstream scheme that converges to the vanishing capillarity solution for countercurrent two-phase flow in two-rock media B. Andreianov; C. Cances 2014 |
10.1007/s10596-014-9403-5 |
A phenotypic and mechanistic perspective on heterogeneity of HER2-positive breast cancers A. Ferrari; A.S. Sertier; A. Vincent-Salomon; X. Pivot; I. Pauporte; P. Saintigny; D. Birnbaum; A. Viari 2016 |
10.1080/23723556.2016.1232186 |
A PHM System Approach: Application to a Simplified Aircraft Bleed System J. Maitre; J.Sen Gupta; K. Medjaher; N. Zerhouni 2016 |
|
A physical-based constitutive model for surface integrity prediction in machining of OFHC copper L.A. Denguir; J.C. Outeiro; G. Fromentin; V. Vignal; R. Besnard 2017 |
10.1016/j.jmatprotec.2017.05.009 |
A physics-based approach to relate grinding process parameters to tribological behavior of ground surfaces O. Fergani; M. Yousfi; Z. Ding; T. Welo; S.Y. Liang 2017 |
10.1007/s00170-017-0111-x |
A piezo-shunted kirigami auxetic lattice for adaptive elastic wave filtering M. Ouisse; M. Collet; F. Scarpa 2016 |
10.1088/0964-1726/25/11/115016 |
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis C. Corpechot; O. Chazouilleres; A. Rousseau; A. Le Gruyer; F. Habersetzer; P. Mathurin; O. Goria; P. Potier; A. Minello; C. Silvain; A. Abergel; M. Debette-Gratien; D. Larrey; O. Roux; J.P. Bronowicki; J. Boursier; V. De Ledinghen; A. Heurgue-Berlot; E. Nguyen-Khac; F. Zoulim; I. Ollivier-Hourmand; J.P. Zarski; G. Nkontchou; S. Lemoinne; L. Humbert; D. Rainteau; G. Lefevre; L. de Chaisemartin; S. Chollet-Martin; F. Gaouar; F.H. Admane; T. Simon; R. Poupon 2018 |
10.1056/NEJMoa1714519 |
A Plant Extract Acts Both as a Resistance Inducer and an Oomycide Against Grapevine Downy Mildew Y. Krzyzaniak; S. Trouvelot; J. Negrel; S. Cluzet; J. Valls; T. Richard; A. Bougaud; L. Jacquens; A. Klinguer; A. Chiltz; M. Adrian; M.C. Heloir 2018 |
10.3389/fpls.2018.01085 |
A plant perspective on nitrogen cycling in the rhizosphere D. Moreau; R.D. Bardgett; R.D. Finlay; D.L. Jones; L. Philippot 2019 |
10.1111/1365-2435.13303 |
A plant-functional-type approach tailored for stakeholders involved in field studies to predict forage services and plant biodiversity provided by grasslands M. Duru; C. Jouany; J.P. Theau; S. Granger; P. Cruz 2015 |
10.1111/gfs.12129 |
A plea for the pathogenic role of immune complexes in severe Covid-19 D.A. Vuitton; L. Vuitton; E. Seilles; P. Galanaud 2020 |
10.1016/j.clim.2020.108493 |
A plea to remove the word ``condyle'' from the international anatomical nomenclature O. Trost; F. Crampon; G. Prum; P. Trouilloud; F. Duparc 2020 |
10.1007/s00276-019-02296-7 |
A Polymer-Free Paclitaxel-Eluting Stent (Zilver PTX) Versus a Bare-Metal Stent (Misago) for De Novo Femoropopliteal Lesions (BATTLE): A Randomized Trial Y. Goueffic; A. Sauguet; P. Desgranges; P. Feugier; E. Rosset; E. Ducasse; A. Cardon; L.Salomon Du Mont; J.Marc Pernes; P. Commeau; P. Lermusiaux; B. Leclere; B. Guyomarch; C. Hoffmann; B. Maurel 2019 |
10.1016/j.jacc.2019.08.097 |
A Polymer-Free Paclitaxel-Eluting Stent Versus a Bare-Metal Stent for De Novo Femoropopliteal Lesions The BATTLE Trial Y. Goueffic; A. Sauguet; P. Desgranges; P. Feugier; E. Rosset; E. Ducasse; A. Kaladji; L.Salomon Du Mont; J.Marc Pernes; P. Commeau; P. Lermusiaux; B. Leclere; B. Guyomarc'h; C.T. Hoffmann; B. Maurel 2020 |
10.1016/j.jcin.2019.12.028 |
A polymorphism in the T(H)2 locus control region is associated with changes in DNA methylation and gene expression M. Schieck; V. Sharma; S. Michel; A.A. Toncheva; L. Worth; D.P. Potaczek; J. Genuneit; A. Kretschmer; M. Depner; J.C. Dalphin; J. Riedler; R. Frei; J. Pekkanen; J. Tost; M. Kabesch 2014 |
10.1111/all.12450 |